CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-16 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise · Restricted Stock Units | −24,193 | 0 | ||
| 2024-02-16 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise · Restricted Stock Units | −946 | 6,626 | ||
| 2024-02-16 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise · Restricted Stock Units | −17,369 | 208,420 | ||
| 2024-02-16 | HOMCY CHARLES J Director | Option exercise | +3,760 | 1,231,594 | ||
| 2024-02-16 | HOMCY CHARLES J Director | Shares withheld for taxes | −1,509 | $37.21 | $56K | 1,230,085 |
| 2024-02-16 | HOMCY CHARLES J Director | Option exercise · Restricted Stock Units | −3,760 | 0 | ||
| 2024-02-16 | Kumar Neil CEO and President | Option exercise | +102,249 | 4,915,446 | ||
| 2024-02-16 | Kumar Neil CEO and President | Shares withheld for taxes | −47,922 | $37.21 | $1.8M | 4,867,524 |
| 2024-02-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units | −5,129 | 5,130 | ||
| 2024-02-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units | −2,394 | 9,577 | ||
| 2024-02-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units | −61,182 | 0 | ||
| 2024-02-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units | −33,544 | 402,528 | ||
| 2024-02-15 | Valantine Hannah Director | Option exercise 10b5-1 | +2,915 | $8.45 | $25K | 4,679 |
| 2024-02-15 | Valantine Hannah Director | Sale 10b5-1 | −2,915 | $37.75 | $110K | 1,764 |
| 2024-02-15 | Valantine Hannah Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,915 | 93,261 | ||
| 2024-01-16 | Valantine Hannah Director | Option exercise 10b5-1 | +2,915 | $8.45 | $25K | 4,679 |
| 2024-01-16 | Valantine Hannah Director | Sale 10b5-1 | −2,915 | $37.97 | $111K | 1,764 |
| 2024-01-16 | Valantine Hannah Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,915 | 96,176 | ||
| 2023-12-26 | MCCORMICK FRANK Director | Sale 10b5-1 | −100,000 | $42.06 | $4.2M | 627,689 |
| 2023-12-18 | Scott Randal W. Director | Sale 10b5-1 | −2,000 | $40.00 | $80K | 9,000 |
Page 26 of 32 · 638 trades